Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores

BACKGROUND & AIMS: It is unclear if hepatocellular carcinoma (HCC) risk declines over time after hepatitis C virus (HCV) eradication. We analyzed changes in HCC annual incidence over time following HCV eradication and identified dynamic markers of HCC risk. METHODS: We identified 48,135 patients...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Gastroenterology
Asıl Yazarlar: Ioannou, George N., Beste, Lauren A, Green, Pamela K., Singal, Amit G., Tapper, Elliot B., Waljee, Akbar K., Sterling, Richard K., Feld, Jordan J., Kaplan, David E., Taddei, Tamar H., Berry, Kristin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6815714/
https://ncbi.nlm.nih.gov/pubmed/31356807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2019.07.033
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller